SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001213900-22-071487
Filing Date
2022-11-14
Accepted
2022-11-14 06:22:02
Documents
81
Period of Report
2022-09-30

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT f10q0922_inmedpharma.htm   iXBRL 10-Q 926052
2 CERTIFICATION f10q0922ex31-1_inmedpharma.htm EX-31.1 11644
3 CERTIFICATION f10q0922ex31-2_inmedpharma.htm EX-31.2 11722
4 CERTIFICATION f10q0922ex32-1_inmedpharma.htm EX-32.1 3857
5 CERTIFICATION f10q0922ex32-2_inmedpharma.htm EX-32.2 3676
11 GRAPHIC image_001.jpg GRAPHIC 4199
12 GRAPHIC fin_001.jpg GRAPHIC 4178
  Complete submission text file 0001213900-22-071487.txt   4581463

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE inm-20220930.xsd EX-101.SCH 69773
7 XBRL CALCULATION FILE inm-20220930_cal.xml EX-101.CAL 25024
8 XBRL DEFINITION FILE inm-20220930_def.xml EX-101.DEF 226853
9 XBRL LABEL FILE inm-20220930_lab.xml EX-101.LAB 438697
10 XBRL PRESENTATION FILE inm-20220930_pre.xml EX-101.PRE 240210
75 EXTRACTED XBRL INSTANCE DOCUMENT f10q0922_inmedpharma_htm.xml XML 502430
Mailing Address SUITE 310, 815 W. HASTINGS STREET VANCOUVER A1 V6C 1B4
Business Address SUITE 310, 815 W. HASTINGS STREET VANCOUVER A1 V6C 1B4 (604) 669-7207
InMed Pharmaceuticals Inc. (Filer) CIK: 0001728328 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 0630
Type: 10-Q | Act: 34 | File No.: 001-39685 | Film No.: 221379787
SIC: 2834 Pharmaceutical Preparations